Actualización en el tratamiento de COVID-19

À l'heure actuelle, tous les pays du monde suivent une pandémie de SARCov2 appelée maladie de COVID-19. Il est nécessaire de connaître le traitement actuellement disponible pour traiter le COVID-19 ; selon les preuves actuelles, il n'existe pas de traitement médicamenteux spécifique. Les études scientifiques à ce jour indiquent que l'hydroxychloroquine ou chloroquine n'est pas un médicament efficace pour réduire la mortalité chez les patients atteints de COVID-19. Le Remdesivir est un médicament qui n'aide pas à l'amélioration clinique, à la mortalité ou au temps d'élimination du virus chez les patients atteints de COVID-19.

Al momento todos los paises del mundo estan cursando conuna Pandemia del SARCov2 denominado enfermedad deCOVID-19.Se hace necesario conocer el tratamiento disponible al momentopara tratar el COVID-19; segun la evidencia actual noexiste un tratamiento farmacologico especifico.Los estudios cientificos a la presente fecha indican que laHidroxicloroquina o cloroquina no es un medicamento eficazpara reducir la mortalidad en pacientes con Covid-19.El Remdesivir es un farmaco que no ayuda a la mejoria clinica,mortalidad o tiempo de eliminacion del virus en pacientescon Covid-19.

At the moment all countries in the world are experiencing a SARCov2 pandemic called COVID-19 disease. It is necessary to know the treatment available at the moment to treat COVID-19; according to current evidence there is no specific pharmacological treatment. Scientific studies to date indicate that Hydroxychloroquine or chloroquine is not an effective drug to reduce mortality in patients with Covid-19. Remdesivir is a drug that does not help clinical improvement,mortality or elimination time of the virus in patients with Covid-19.

في الوقت الحالي، تعاني جميع دول العالم من جائحة SARCov2 تسمى مرض COVID -19. من الضروري معرفة العلاج المتاح في الوقت الحالي لعلاج COVID -19 ؛ وفقًا للأدلة الحالية، لا يوجد علاج دوائي محدد. تشير الدراسات العلمية حتى الآن إلى أن هيدروكسي كلوروكين أو الكلوروكين ليس دواءً فعالًا لتقليل الوفيات لدى مرضى Covid -19. Remdesivir هو دواء لا يساعد في التحسن السريري أو الوفيات أو وقت التخلص من الفيروس لدى مرضى Covid -19.

Related Organizations

Hospital General Docente de Calderón
Ecuador
Hospital Vozandes
Ecuador
Central University of Ecuador
Ecuador

Keywords

pandemia, cloroquina, hidroxicloroquina, lopinavir/ritonavir, remdesivir., Health, Toxicology and Mutagenesis, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Social Sciences, FOS: Law, Outbreak, Infectious disease (medical specialty), Coronavirus disease 2019 (COVID-19), Public Health and Environmental Management, Virology, Environmental Science, Physical Sciences, Health Sciences, Pathology, Medicine, Surgery, Disease, Therapy, Legal Education and Human Rights, Advancements in Medical Science and Practice, Law, 2019-20 coronavirus outbreak

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average